AC Immune (ACIU) Enterprise Value (2016 - 2025)
AC Immune (ACIU) has disclosed Enterprise Value for 10 consecutive years, with -$114.4 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 39.46% to -$114.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$114.4 million through Dec 2025, up 39.46% year-over-year, with the annual reading at -$114.4 million for FY2025, 39.46% up from the prior year.
- Enterprise Value for Q4 2025 was -$114.4 million at AC Immune, up from -$188.9 million in the prior quarter.
- The five-year high for Enterprise Value was -$114.4 million in Q4 2025, with the low at -$215.0 million in Q4 2021.
- Average Enterprise Value over 5 years is -$152.3 million, with a median of -$127.2 million recorded in 2022.
- The sharpest move saw Enterprise Value surged 40.81% in 2022, then plummeted 62.61% in 2024.
- Over 5 years, Enterprise Value stood at -$215.0 million in 2021, then soared by 40.81% to -$127.2 million in 2022, then rose by 8.7% to -$116.2 million in 2023, then plummeted by 62.61% to -$188.9 million in 2024, then soared by 39.46% to -$114.4 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods came in at -$114.4 million, -$188.9 million, and -$116.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.